Heart Failure Clinical Research Network Regional Clinical Center (U10)
Heart Failure Clinical Research Network Regional Clinical Center (U10)
批准号:
8985611
负责人:
GARY M FELKER
金额:
$50.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2018-12-31
关键词:
Academic Medical CentersAchievementAcuteAddressAncillary StudyBasic ScienceBiometryClinicalClinical InvestigatorClinical ProtocolsClinical ResearchClinical Research ProtocolsClinical Trials Data Monitoring CommitteesClinical Trials DesignCollaborationsCommunitiesCost effectiveness researchDataData AnalysesData CollectionData Coordinating CenterData QualityDevelopmentDiagnosisEnvironmentEpidemiologyEthnic OriginFuture GenerationsGenderGoalsHealthHeart failureInternationalInterventionMaster&aposs DegreeMeasuresMorbidity - disease rateNational Heart, Lung, and Blood InstituteParticipantPatient CarePatient RecruitmentsPatientsPerformancePersonsPoliciesPopulation HeterogeneityPreventionPrincipal InvestigatorProceduresProtocols documentationRaceRandomized Clinical TrialsRecruitment ActivityResearchResearch DesignResearch InfrastructureResearch PersonnelResearch TrainingResolutionReview CommitteeScienceSite VisitSkills DevelopmentStatistical MethodsSyndromeTherapy EvaluationTimeLineTrainingTraining ProgramsUnderrepresented PopulationsWritingbaseclinical investigationdesignethnic diversityexperiencefollow-uphuman subject protectionimprovedimproved outcomeinnovationmeetingsnext generationnovelnovel therapeuticspatient orientedprotocol developmentquality assuranceracial diversityresearch and developmentskill acquisitionskillssuccesssymposiumtocol
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Composite
PROJECT SUMMARY
The overriding objective of this proposal for the Duke University Medical Center Regional Clinical
Center (Duke RCC) for the Heart Failure Clinical Research Network (HF Network) is to improve the
care of patients with heart failure through high-impact patient-oriented clinical research. This objective
will be achieved through active collaboration with all components of the HF Network, including other
RCCs, the Data Coordinating Center (DCC), associated core labs, and the NHLBI. The overall goal of
the HF network is to improve outcomes through optimal application of existing therapies, evaluation of
novel therapies, and to facilitate application of emerging basic science discoveries into clinical
investigations. We believe the Duke RCC is highly capable of contributing to the successful
achievement of these objectives based on a demonstrated record of developing original, innovative,
high impact clinical research protocols addressing clinically important research questions in heart
failure, and propose a novel protocol targeting acute heart failure patients, the CAPTAIN study, in this
application. The Duke RCC has proven ability to recruit scientifically appropriate and ethnically and
racially diverse populations of patients into HF Network clinical protocols and provide data that is
accurate, complete, timely, and regulatory compliant. As detailed in this proposal, the Duke RCC has
a dedicated and experienced team of investigators, combining a broad array of clinical, research, and
operational skills that collectively will make a major contribution to the overall success of the HF
Network. The Duke RCC we will participate in the development of research protocols, statistical
methods, and plans for data collection and protocol implementation. We will provide input where
appropriate into study design from both a scientific and a feasibility standpoint. We will implement
each network-wide protocol approved by the protocol review committee (PRC) and the NHLBI; comply
with study policies and quality assurance measures approved by the Steering Committee, and agree
to oversight of the study by a Data and Safety Monitoring Board (DSMB). Finally, the Duke RCC will
develop a Clinical Research Skills Development Core to train future generations of heart failure
researchers.
RELEVANCE (See instnjctions):
This proposal for the Duke Regional Clinical Center of the NHLBI Heart Failure Clinical Research
Network will develop and implement high impact, scientifically rigorous randomized clinical trials
designed to improve the health of persons with heart failure. The results of the proposed research
will have immediate clinical implications for millions of patients with heart failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
-
批准号:8479426
-
项目类别:
-
资助金额:$488.35万
-
财政年份:2012
-
负责人:GARY M FELKER
-
依托单位:
Heart Failure Clinical Research Network Regional Clinical Center (U10)
-
批准号:8791701
-
项目类别:
-
资助金额:$50.81万
-
财政年份:2012
-
负责人:GARY M FELKER
-
依托单位:
Heart Failure Clinical Research Network Regional Clinical Center (U10)
-
批准号:8196429
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2012
-
负责人:GARY M FELKER
-
依托单位:
Heart Failure Clinical Research Network Regional Clinical Center (U10)
-
批准号:8403731
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2012
-
负责人:GARY M FELKER
-
依托单位:
Heart Failure Clinical Research Network Regional Clinical Center (U10)
-
批准号:8600722
-
项目类别:
-
资助金额:$50.55万
-
财政年份:2012
-
负责人:GARY M FELKER
-
依托单位:
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
-
批准号:8235442
-
项目类别:
-
资助金额:$314.13万
-
财政年份:2012
-
负责人:GARY M FELKER
-
依托单位:
Inflammation & Prognosis in Decompensated Heart Failure
-
批准号:7217256
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2004
-
负责人:GARY M FELKER
-
依托单位:
Inflammation & Prognosis in Decompensated Heart Failure
-
批准号:6868910
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2004
-
负责人:GARY M FELKER
-
依托单位:
Inflammation & Prognosis in Decompensated Heart Failure
-
批准号:7371004
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2004
-
负责人:GARY M FELKER
-
依托单位:
Inflammation & Prognosis in Decompensated Heart Failure
-
批准号:7046062
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2004
-
负责人:GARY M FELKER
-
依托单位:
Inflammation & Prognosis in Decompensated Heart Failure
-
批准号:6710882
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2004
-
负责人:GARY M FELKER
-
依托单位:
海外基金